Page 3 - Eterna Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eterna therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eterna Therapeutics Today - Breaking & Trending Today

Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science

Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Matt Angel , Raven Hinkel , Elizabeth Belcher , Christopher Rohde , Prnewswire Factor Bioscience Inc , Department Of Research , Technology Officer , Vanderbilt University , Lehigh University , Associate Scientists , Chief Technology , Eterna Therapeutics , Chemical Engineering ,

Head to Head Comparison: BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA)

BriaCell Therapeutics (OTCMKTS:BCTXF – Get Free Report) and Eterna Therapeutics (NASDAQ:ERNA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Volatility & Risk BriaCell Therapeutics has a […] ....

United Kingdom , United States , British Columbia , Charlesl Wiseman , Isaacb Maresky , Eterna Therapeutics Inc , Brooklyn Immunotherapeutics Inc , Briacell Therapeutics Corp , Briacell Therapeutics , Get Free Report , Eterna Therapeutics , Cell Therapeutics , Eterna Therapeutic , West Vancouver , Briacell Therapeutics Daily , Otcmkts Bctxf , Stock Comparison , Stock Analysis ,

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a ....

University Of Washington , United States , Brianm Culley , Charlotte Hubbert , Corporate Development , University Of Washington Innovation Roundtable , Accelerator Corporation , Exchange Commission , Head Of Gates Foundation Venture Capital , Melinda Gates Foundation Strategic Investment Fund , Eterna Therapeutics Inc , Duke University , Roche Group , Vp Corporate Development , Fred Hutch Cancer Institute Evergreen Fund , Institute For Stem Cells , Columbia University , Madrona Venture Group , Kauffman Society Of Fellows , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Vice President , Gates Foundation Venture Capital , Beckman Research Institute , Strategic Director , Madrona Venture ,

Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 33,600 shares, a drop of 11.1% from the February 29th total of 37,800 shares. Based on an average daily volume of 12,300 shares, […] ....

Vanguard Group Inc , Goldman Sachs Group Inc , Eterna Therapeutics Company Profile , Geode Capital Management , Eterna Therapeutics Inc , Renaissance Technologies , Eterna Therapeutics , Get Free Report , Sachs Group , Capital Management , Capital Advisors , Therapeutics Inc , Eterna Therapeutics Daily ,